ACUTE AND LONG-TERM RESPONSE TO MK-421, A LONG-ACTING ORAL CONVERTING ENZYME-INHIBITOR, IN HEART-FAILURE

被引：0
|
作者：
LEVINE, TB [1 ]
OLIVARI, MT [1 ]
COHN, JN [1 ]
机构：
[1] UNIV MINNESOTA,MINNEAPOLIS,MN 55455
来源：
CIRCULATION | 1982年 / 66卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：209 / 209
页数：1
相关论文
共 50 条
  • [11] EFFECTS OF THE NEW ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR MK-421 IN HUMAN HYPERTENSION
    GAVRAS, H
    BIOLLAZ, J
    WAEBER, B
    BRUNNER, HR
    GAVRAS, I
    DAVIES, RO
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 1982, 4 (1-2) : 303 - 314
  • [12] MK-421 - A NEW ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR FOR ESSENTIAL-HYPERTENSION
    FERGUSON, RK
    VLASSES, PH
    SWANSON, BN
    COOPER, DJ
    DAVIES, RO
    ABRAMS, WB
    AMERICAN JOURNAL OF CARDIOLOGY, 1981, 47 (02): : 470 - 470
  • [13] EFFECTS OF THE ORAL ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR MK-421 IN HUMAN HYPERTENSION
    GAVRAS, H
    BIOLLAZ, J
    WAEBER, B
    BRUNNER, HR
    GAVRAS, I
    SACKEL, H
    CHAROCOPOS, F
    DAVIES, RO
    CLINICAL SCIENCE, 1981, 61 : S281 - S283
  • [14] PHARMACOLOGICAL PROPERTIES OF THE CONVERTING ENZYME-INHIBITOR, ENALAPRIL MALEATE (MK-421)
    SWEET, CS
    FEDERATION PROCEEDINGS, 1983, 42 (02) : 167 - 170
  • [15] EFFECT OF THE CONVERTING ENZYME-INHIBITOR (CEI) MK-421 ON ISCHEMIC ACUTE-RENAL-FAILURE (ARF) IN THE RAT
    KOELZ, AM
    BRUNNER, FP
    WUNDERLICH, P
    THIEL, GT
    KIDNEY INTERNATIONAL, 1983, 23 (06) : 902 - 902
  • [16] ORAL CONVERTING ENZYME-INHIBITOR IN RESISTANT HEART-FAILURE
    FOUAD, FM
    CEIMO, JK
    TARAZI, RC
    BRAVO, EL
    CLINICAL RESEARCH, 1979, 27 (04): : A673 - A673
  • [17] SUSTAINED BENEFICIAL HEMODYNAMIC-EFFECTS OF LONG-TERM ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR IN CHRONIC HEART-FAILURE
    ADER, R
    CHATTERJEE, K
    PORTS, T
    HIRAMATSU, B
    BRUNDAGE, B
    PARMLEY, W
    CIRCULATION, 1979, 60 (04) : 130 - 130
  • [18] ACUTE HEMODYNAMIC-EFFECTS OF CGS14824A, A NEW ORAL LONG-ACTING ANGIOTENSIN CONVERTING ENZYME-INHIBITOR IN PATIENTS WITH SEVERE CONGESTIVE HEART-FAILURE
    INSEL, J
    MIRVIS, DM
    BOLAND, MJ
    CINQUEGRANI, MP
    SHANES, J
    RUBIN, S
    WHALEN, J
    CLINICAL RESEARCH, 1988, 36 (01): : A32 - A32
  • [19] ENALAPRIL - A LONG-ACTING ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR
    BOREK, M
    CHARLAP, S
    FRISHMAN, W
    PHARMACOTHERAPY, 1987, 7 (05): : 133 - 148
  • [20] MK-521 - A LONG-ACTING, NON-SULFHYDRYL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR
    ROTMENSCH, HH
    VLASSES, PH
    SWANSON, BN
    DAVIES, RO
    MERRILL, DD
    FERGUSON, RK
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (02) : 210 - 210
12345